Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/03/22 → 30/06/24 |
Funding
- Scottish Executive: £3,779.18
- Scottish Executive: £88,073.29
- Scottish Executive: £231,569.74
Target-Type 2: Targeting investigation and treatment in Type 2 Myocardial Infarction (TARGET Type 2): A pilot randomied controlled trial
- Chapman, Andrew (Principal Investigator)
- Ferry, Amy (Co-investigator)
- Lewis, Steff (Co-investigator)
- Mills, Nicholas (Co-investigator)
- Salman, Rustam (Co-investigator)
- Tuck, Chris (Co-investigator)